SIM0518 not checked

Jiangsu Simcere Pharmaceutical Co., Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1 trial completes
Trials
1 active
1 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“SIM0518 is an oral, next-generation, highly selective ALK/ROS1 dual inhibitor. Bupropion is a sensitive probe substrate for cytochrome P2B6 SIM0518+Repaglinide”In the company’s words, NCT07912268 on ClinicalTrials.gov
Tested for
ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Main trialPhase 1
“This is a multicenter, open-label, Phase I study designed to evaluate the safety, tolerability, efficacy, and pharmacokinetic /pharmacodynamic characteristics of SIM0518 in trial participants with ALK-positive or ROS1-positive locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC). The study starts with a dose escalation part (Part 1), followed by a dose expansion part (Part 2). A Drug-Drug Interaction (DDI) study (Part 3) may be conducted after the Recommended Dose of SIM0518 is determined.”In the company’s words, NCT07912268 on ClinicalTrials.gov

Other drugs for ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

All 560 drugs for ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1Not yet recruiting 1 Dec 2028 Study of SIM0518 in Participants With ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow SIM0518

Following is part of Solo: you see every change to SIM0518 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in